Back to results

CompletedPhase 2

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

NCT00743002

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Artesia, California, United States

+19 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2008-08
Enrollment: 87 participants
Sponsor: OPKO Health, Inc.
Purpose: treatment

Locations (20)

Artesia, California, United States
Los Angeles, California, United States
Santa Ana, California, United States
Torrence, California, United States
Walnut Creek, California, United States
DeLand, Florida, United States
Bloomingdale, Illinois, United States
Grand Rapids, Michigan, United States
St Louis, Missouri, United States
Las Vegas, Nevada, United States
Clifton, New Jersey, United States
Asheboro, North Carolina, United States
Wilmington, North Carolina, United States
Bensalem, Pennsylvania, United States
Athens, Tennessee, United States
Corpus Christi, Texas, United States
Dallas, Texas, United States
Houston, Texas, United States
Richmond, Texas, United States
San Antonio, Texas, United States

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione — TrialFind